Cruiser Capital Advisors LLC Purchases 10,000 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

Cruiser Capital Advisors LLC lifted its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 15.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 74,458 shares of the company’s stock after buying an additional 10,000 shares during the period. Core Scientific makes up about 0.6% of Cruiser Capital Advisors LLC’s holdings, making the stock its 21st largest holding. Cruiser Capital Advisors LLC’s holdings in Core Scientific were worth $1,046,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CORZ. Wealth Enhancement Advisory Services LLC lifted its stake in Core Scientific by 25.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock valued at $1,378,000 after purchasing an additional 20,000 shares during the last quarter. Mirabella Financial Services LLP acquired a new position in Core Scientific in the 3rd quarter valued at $18,383,000. Capstone Investment Advisors LLC increased its position in Core Scientific by 113.4% during the 3rd quarter. Capstone Investment Advisors LLC now owns 55,000 shares of the company’s stock worth $652,000 after buying an additional 29,230 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Core Scientific by 44.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,932,462 shares of the company’s stock worth $22,919,000 after buying an additional 590,946 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Core Scientific by 48.0% in the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock valued at $5,192,000 after acquiring an additional 142,068 shares during the period.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Compass Point lowered their price target on shares of Core Scientific from $26.00 to $20.00 and set a “buy” rating on the stock in a research report on Tuesday, February 25th. Cantor Fitzgerald dropped their price target on shares of Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Craig Hallum assumed coverage on Core Scientific in a research note on Tuesday, January 21st. They issued a “buy” rating and a $24.00 price target for the company. Needham & Company LLC lowered their price objective on Core Scientific from $18.00 to $17.00 and set a “buy” rating on the stock in a research note on Thursday, February 27th. Finally, Keefe, Bruyette & Woods initiated coverage on Core Scientific in a report on Monday, January 27th. They set an “outperform” rating and a $22.00 target price on the stock. Fifteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $19.07.

Core Scientific Trading Up 9.4 %

CORZ stock opened at $9.31 on Tuesday. The stock has a market capitalization of $2.74 billion, a P/E ratio of -1.72 and a beta of 6.83. The firm has a 50-day moving average price of $11.41 and a 200-day moving average price of $13.18. Core Scientific, Inc. has a 12 month low of $2.61 and a 12 month high of $18.63.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million during the quarter, compared to analyst estimates of $97.07 million. As a group, equities analysts predict that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

Insider Activity at Core Scientific

In other news, insider Todd M. Duchene sold 25,277 shares of the firm’s stock in a transaction on Friday, January 24th. The shares were sold at an average price of $16.24, for a total transaction of $410,498.48. Following the completion of the transaction, the insider now owns 2,023,423 shares of the company’s stock, valued at approximately $32,860,389.52. This trade represents a 1.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Adam Taylor Sullivan sold 369,712 shares of Core Scientific stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $6,004,122.88. Following the transaction, the chief executive officer now owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. This trade represents a 8.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 748,282 shares of company stock valued at $10,978,104 in the last 90 days. 32.00% of the stock is owned by corporate insiders.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.